WHITE LABEL MANUFACTURER · MEDICAL DEVICES

Hydrocolloid dressing manufacturer
white label

For the treatment of chronic wounds. Reimbursed by LPP, certified ISO 13485 and MDR. Manufactured under your brand for pharmacies, groups, and laboratories.

ISO 13485

MDR 2017/745

CE Marking

Reimbursed LPP

Request a quote
Discover our offer
Hydrocolloid dressing
Order

Product Data Sheet :

  • Reference  GB-HDC
  • Types  Occlusive hydrocolloid dressing
  • Composition Sodium carboxymethylcellulose
  • Shapes Thin plaque · Thick plaque · Anatomical (sacrum, heel)
  • Formats 10x10 · 15x15 · 10x12 (oval) · custom
  • Properties Occlusive · Healthy skin adhesive · Non-adherent to the wound
  • Certifications ISO 13485 · MDR 2017/745 · CE Marking
  • LPP Reimbursement Title I, Chapter 3, Section 1
  • Indications Chronic wounds · Pressure ulcers · Ulcers
  • Renewal To saturation, up to 7 days maximum
  • Minimum Order Quantity On quote according to format and packaging
  • Time-to-market 4 to 6 months (first order)
  • Renewal 6 to 10 weeks
  • Packaging Fully customized to your brand (logo, guidelines, mandatory mentions)
  • Delivery France · Europe · Export

What is a hydrocolloid dressing?

The hydrocolloid dressing is a dressing occlusive based on sodium carboxymethylcellulose. Upon contact with wound exudates, its inner layer transforms into a gel, creating a warm, humid environment conducive to healing. It adheres to healthy skin without sticking to the wound, making its removal painless.

It is indicated for the chronic wounds with low to moderate exudate for healthy skin: pressure ulcers, ulcers, abrasions. Listed in the List of Reimbursable Products and Services (LPP) under Title I, Chapter 3, it is among the dressings covered by Health Insurance with a prescription.

When to use a hydrocolloid dressing

Effectively targeting indications means offering your pharmacies a range of products suited to patients' real needs.

 Recommended indications

  • Chronic wounds with low to moderate exudate
  • Bedsores and leg ulcers
  • Healthy wound edges, no superinfection
  • Budding and epidermalization phase
  • Abrasions and blisters (fine forms)
  • Transparent adhesive secondary dressing

Contraindications

  • Infected wounds (occlusive nature)
  • Diabetic foot ulcers
  • Dry necrosis
  • Heavily exuding wounds
  • Known allergy to one of the components (colophony adhesive)

They trust us
Our partners
Laboratories, pharmaceutical groups, and distributors who trust us.

  • Pharmaceutical Partner
  • Pharmaceutical factory partner
  • Pharmaceutical factory partner
  • Pharmaceutical factory partner

Today we are supporting several major players in the pharmaceutical sector, such as’Evolupharm, Pharma Best or else Juvasanté, in the development and manufacturing of their private label physiological serums.

A leading industrial player

Means of production worthy of your ambitions

References
manufactured and shipped

Months on average 
time to market

Partners who
trust us

Units produced per year

FAQ - What Pharmacists and B2B Buyers Ask Us

Yes. Since 2022, LPP reimbursement is done through individual codes assigned by brand. By having their bandages manufactured under a white label by a certified manufacturer, a group can market a reimbursed range under its own name.

It is indicated for chronic wounds with low to moderate exudate and healthy edges: bedsores, ulcers, and abrasions. It is contraindicated for infected wounds, diabetic foot, and dry necrosis.

The MOQ varies depending on the shapes and formats ordered. Contact us for a quote tailored to your volume — we support regional groups as well as national networks.

Yes. In addition to standard plates, we produce anatomical shapes designed for specific locations (sacrum, heel), as well as thin and thick shapes depending on the exudate level of the wounds.

4 to 6 months for a first launch (briefing, development, production, shipping). For renewals on existing reference: 6 to 10 weeks.